8 research outputs found
Respiratory outcome of prematurely born infants following human rhinovirus A and C infections
No full textHigh-Flow Nasal Cannula, a Boon or a Bane for COVID-19 Patients? An Evidence-Based Review
No full textHeat Shock Protein 70 Secretion by Neonatal Tracheal Tissue During Mechanical Ventilation: Association With Indices of Tissue Function and Modeling
No full textEchinacea Reduces the Risk of Recurrent Respiratory Tract Infections and Complications: A Meta-Analysis of Randomized Controlled Trials
No full text
Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure.
Get PDFHigh flow nasal cannula (HFNC) supportive therapy has emerged as a safe, useful therapy in patients with respiratory failure, improving oxygenation and comfort. Recently several clinical trials have analyzed the effectiveness of HFNC therapy in different clinical situations and have reported promising results. Here we review the current knowledge about HFNC therapy, from its mechanisms of action to its effects on outcomes in different clinical situations.Fisher & Paykel support a post doctoral fellow in Medical Research at the Hospital del Mar Institute. OR, GH, and JRM have had travel expenses covered by Fisher & Paykel
